Artemisinin: Mechanisms of action, resistance and toxicity

International Journal for Parasitology

Volumn 32, Issue 13, 2002, Pages 1655-1660

  Meshnick, Steven R ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Antimalarial; Artemisinin; Endoperoxide; Malaria; Plasmodium; Qinghaosu

Indexed keywords

ARTEMISININ; BRIDGED COMPOUND; ENDOPEROXIDE; FREE RADICAL; TUMOR PROTEIN;

DRUG DEVELOPMENT; MALARIA;

CONFERENCE PAPER; DECOMPOSITION; DRUG MECHANISM; DRUG RESISTANCE; DRUG SELECTIVITY; MALARIA; NEUROTOXICITY; NONHUMAN; PLASMODIUM;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; HUMANS; PLASMODIUM; SESQUITERPENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037021405     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(02)00194-7     Document Type: Conference Paper

References (95)

1. Adams P.A., Berman P.A. Reaction between ferriprotoporphyrin IX and the antimalarial endoperoxide artesunate gives an intermediate species with enhanced redox catalytic activity. J. Pharm. Pharmacol. 48:1996;183-187.
2. Antimalarials C.C.R.G.o.Q.a.I.D.a. Chemical studies on qinghaosu (artemisinine). J. Tradit. Chin. Med. 2:1972;3-8.
3. Asawamahasakda W., Ittarat I., Chang C.C., McElroy P., Meshnick S.R. Effects of antimalarials and protease inhibitors on plasmodial hemozoin production. Mol. Biochem. Parasitol. 67:1994;183-191.
4. Asawamahasakda W., Ittarat I., Pu Y.M., Ziffer H., Meshnick S.R. Reaction of antimalarial endoperoxides with specific parasite proteins. Antimicrob. Agents Chemother. 38:1994;1854-1858.
5. Avery M.A., Alvim-Gaston M., Rodrigues C.R., Barreiro E.J., Cohen F.E., Sabnis Y.A., Woolfrey J.R. Structure-activity relationships of the antimalarial agent artemisinin 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies. J. Med. Chem. 45:2002;292-303.
6. Bachi M.D., Korshin E.E., Hoos R., Szpilman A.M. Synthesis and reactions of antimalarial bicyclic peroxides. J. Heterocycl. Chem. 37:2000;639-646.
7. Benoit-Vical F., Robert A., Meunier B. In vitro and in vivo potentiation of artemisinin and synthetic endoperoxide antimalarial drugs by metalloporphyrins [In Process Citation]. Antimicrob. Agents Chemother. 44:2000;2836-2841.
8. Berman P.A., Adams P.A. Artemisinin enhances heme-catalysed oxidation of lipid membranes. Free Radic. Biol. Med. 22:1997;1283-1288.
9. Bharel S., Vishwakarma R.A., Jain S.K. Artemisinin mediated alteration of haemin to a delta-meso oxidation product: relevance to mechanism of action. J. Chem. Soc. Perkin Trans. 1:1998;2163-2166.
10. Bhisutthibhan J., Meshnick S.R. Immunoprecipitation of [(3)H]dihydroartemisinin translationally controlled tumor protein (TCTP) adducts from Plasmodium falciparum-infected erythrocytes by using anti-TCTP antibodies. Antimicrob. Agents Chemother. 45:2001;2397-2399.
11. Bhisutthibhan J., Pan X.Q., Hossler P.A., Walker D.J., Yowell C.A., Carlton J., Dame J.B., Meshnick S.R. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J. Biol. Chem. 273:1998;16192-16198.
12. Bhisutthibhan J., Philbert M.A., Fujioka M., Aikawa M., Meshnick S.R. The Plasmodium falciparum translationally controlled tumor protein: subcellular localization and calcium binding. Eur. J. Cell Biol. 78:1999;665-670.
13. Brewer T.G., Genovese R.F., Newman D.B., Li Q. Factors relating to neurotoxicity of artemisinin antimalarial drugs 'listening to arteether'. Med. Trop. (Mars). 58:1998;22-27.
14. Brossi A., Venugopalan B., Dominguez Gerpe L., Yeh H.J., Flippen-Anderson J.L., Buchs P., Luo X.D., Milhous W., Peters W. Arteether, a new antimalarial drug: synthesis and antimalarial properties. J. Med. Chem. 31:1988;645-650.
15. Butler A.R., Gilbert B.C., Hulme P., Irvine L.R., Renton L., Whitwood A.C. EPR evidence for the involvement of free radicals in the iron-catalysed decomposition of qinghaosu (artemisinin) and some derivatives; antimalarial action of some polycyclic endoperoxides. Free Radic. Res. 28:1998;471-476.
16. Cazelles J., Robert A., Meunier B. Alkylating capacity and reaction products of antimalarial trioxanes after activation by a heme model. J. Org. Chem. 67:2002;609-619.
17. Chen P.Q., Li G.Q., Guo X.B., He K.R., Fu Y.X., Fu L.C., Song Y.Z. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin. Med. J. (Engl.). 107:1994;709-711.
18. Chotivanich K., Udomsangpetch R., Dondorp A., Williams T., Angus B., Simpson J.A., Pukrittayakamee S., Looareesuwan S., Newbold C.I., White N.J. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. J. Infect. Dis. 182:2000;629-633.
19. Cooper R.A., Ferdig M.T., Su X.Z., Ursos L., Mu J., Nomura T., Fujioka H., Fidock D., Roepe P., Wellems T.E. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol. Pharmacol. 61:2002;35-42.
20. Dayan A.D. Neurotoxicity and artemisinin compounds do the observations in animals justify limitation of clinical use? Med. Trop. (Mars). 58:1998;32-37.
21. Duraisingh M.T., Roper C., Walliker D., Warhurst D.C. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol. Microbiol. 36:2000;955-961.
22. Dutta G.P., Bajpai R., Vishwakarma R.A. Artemisinin (qinghaosu) - A new gametocytocidal drug for malaria. Chemotherapy. 35:1989;200-207.
23. Ellis D.S., Li Z.L., Gu H.M., Peters W., Robinson B.L., Tovey G., Warhurst D.C. The chemotherapy of rodent malaria. Ann. Trop. Med. Parasitol. 79:1985;367-374.
24. Fishwick J., Edwards G., Ward S.A., McLean W.G. Morphological and immunocytochemical effects of dihydroartemisinin on differentiating NB2a neuroblastoma cells. Neurotoxicology. 19:1998;393-403.
25. Fishwick J., McLean W.G., Edwards G., Ward S.A. The toxicity of artemisinin and related compounds on neuronal and glial cells in culture. Chem. Biol. Interact. 96:1995;263-271.
26. Geary T.G., Divo A.A., Jensen J.B. Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture. Am. J. Trop. Med. Hyg. 40:1989;240-244.
27. Gogtay N.J., Kadam V.S., Karnad D.R., Kanbur A., Kamtekar K.D., Kshirsagar N.A. Probable resistance to parenteral artemether in Plasmodium falciparum: case reports from Mumbai (Bombay), India. Ann. Trop. Med. Parasitol. 94:2000;519-520.
28. Gu J.D., Chen K.X., Jiang H.L., Leszczynski J. The radical transformation in artemisinin: a DFT study. J. Phys. Chem. 103:1999;9364-9369.
29. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 1999;Clarendon Press, Oxford.
30. Haynes R.K., Pai H.H.O., Voerste A. Ring opening of artemisinin (qinghaosu) and dihydroartemisinin and interception of the open hydroperoxides with formation of N-oxides - A chemical model for antimalarial mode of action. Tetrahedron Lett. 40:1999;15-18.
31. Haynes R.K., Vonwiller S.C. The behaviour of quinghaosu(artemisinin) in the presence of heme iron(II) and (III). Tetrahedron Lett. 37:1996;253-260.
32. Hong Y.L., Yang Y.Z., Meshnick S.R. The interaction of artemisinin with malarial hemozoin. Mol. Biochem. Parasitol. 63:1994;121-128.
33. Inselburg J. Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 34:1985;417-418.
34. Jefford C.W., Favarger F., Vicente M., Jacquier Y. The decomposition of cis-fused cyclopenteno-1,2,4-trioxanes induced by ferrous salts and some oxophilic reagents. Helv. Chim. Acta. 78:1995;452-458.
35. Jiang J.B., Jacobs G., Liang D.S., Aikawa M. Qinghaosu-induced changes in the morphology of Plasmodium inui. Am. J. Trop. Med. Hyg. 34:1985;424-428.
36. Kamchonwongpaisan S., McKeever P., Hossler P., Ziffer H., Meshnick S.R. Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vitro. Am. J. Trop. Med. Hyg. 56:1997;7-12.
37. Kapetanaki S., Varotsis C. Ferryl-oxo heme intermediate in the antimalarial mode of action of artemisinin. FEBS Lett. 474:2000;238-241.
38. Krungkrai S.R., Yuthavong Y. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress. Trans. R. Soc. Trop. Med. Hyg. 81:1987;710-714.
39. Kumar N., Zheng H. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol. Res. 76:1990;214-218.
40. Le Bras J. In vitro susceptibility of African Plasmodium falciparum isolates to dihydroartemisinin and the risk factors for resistance to qinghaosu. Med. Trop. (Mars). 58:1998;18-21.
41. Levander O.A., Ager A.L. Jr, Morris V.C., May R.G. Qinghaosu, dietary vitamin E, selenium, and cod-liver oil: effect on the susceptibility of mice to the malarial parasite Plasmodium yoelii. Am. J. Clin. Nutr. 50:1989;346-352.
42. Luxemburger C., Brockman A., Silamut K., Nosten F., van Vugt M., Gimenez F., Chongsuphajaisiddhi T., White N.J. Two patients with falciparum malaria and poor in vivo responses to artesunate. Trans. R. Soc. Trop. Med. Hyg. 92:1998;668-669.
43. Maeno Y., Toyoshima T., Fujioka H., Ito Y., Meshnick S.R., Benakis A., Milhous W.K., Aikawa M. Morphologic effects of artemisinin in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 49:1993;485-491.
44. McGready R., Cho T., Cho J.J., Simpson J.A., Luxemburger C., Dubowitz L., Looareesuwan S., White N.J., Nosten F. Artemisinin derivatives in the treatment of falciparum malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 92:1998;430-433.
45. McIntosh, H., Olliaro., P., 1999. Artemisinin derivatives for treating severe malaria. Cochrane Database of Systematic Reviews.
46. McIntosh, H., Olliaro., P.,1999. Artemisinin derivatives for treating uncomplicated malaria. Cochrane Database of Systematic Reviews.
47. Meshnick S.R. From quinine to qinghaosu: historical perspectives. Sherman I.W., Malaria: Parasite Biology, Pathogenesis, Protection. 1998;341-353 ASM Press, Washington, DC.
48. Meshnick S.R., Dobson M.J. The history of antimalarial drugs. Antimalarial chemotherapy. Rosenthal P.J., Mechanisms of Action, Modes of Resistance, and New Directions in Drug Development. 2001;15-25 Humana Press, Totowa, NJ.
49. Meshnick S.R., Thomas A., Ranz A., Xu C.M., Pan H.Z. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol. Biochem. Parasitol. 49:1991;181-189.
50. Meshnick S.R., Tsang T.W., Lin F.B., Pan H.Z., Chang C.N., Kuypers F., Chiu D., Lubin B. Activated oxygen mediates the antimalarial activity of qinghaosu. Prog. Clin. Biol. Res. 313:1989;95-104.
51. Meshnick S.R., Yang Y.Z., Lima V., Kuypers F., Kamchonwongpaisan S., Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob. Agents Chemother. 37:1993;1108-1114.
52. Miller L.G., Panosian C.B. Ataxia and slurred speech after artesunate treatment for falciparum malaria [letter] [see comments]. N. Engl. J. Med. 336:1997;1328.
53. Nontprasert A., Nosten-Bertrand M., Pukrittayakamee S., Vanijanonta S., Angus B.J., White N.J. Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice. Am. J. Trop. Med. Hyg. 59:1998;519-522.
54. Nontprasert A., Pukrittayakamee S., Nosten-Bertrand M., Vanijanonta S., White N.J. Studies of the neurotoxicity of oral artemisinin derivatives in mice. Am. J. Trop. Med. Hyg. 62:2000;409-412.
55. Nosten F., Hien T.T., White N.J. Use of artemisinin derivatives for the control of malaria. Med. Trop. (Mars). 58:1998;45-49.
56. Nosten F., van Vugt M., Price R., Luxemburger C., Thway K.L., Brockman A., McGready R., ter Kuile F., Looareesuwan S., White N.J. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 356:2000;297-302.
57. O'Neill P.M., Bishop L.P., Searle N.L., Maggs J.L., Ward S.A., Bray P.G., Storr R.C., Park B.K. The biomimetic iron-mediated degradation of Arteflene (Ro-42-1611), an endoperoxide antimalarial - Implications for the mechanism of antimalarial activity. Tetrahedron Lett. 38:1997;4263-4266.
58. Paitayatat S., Tarnchompoo B., Thebtaranonth Y., Yuthavong Y. Correlation ofantimalarial activity of artemisinin derivatives with binding affinity with ferroprotoporphyrin IX. J. Med. Chem. 40:1997;633-638.
59. Pandey A.V., Tekwani B.L., Singh R.L., Chauhan V.S. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J. Biol. Chem. 274:1999;19383-19388.
60. Peters W., Li Z.L., Robinson B.L., Warhurst D.C. The chemotherapy of rodent malaria. Ann. Trop. Med. Parasitol. 80:1986;483-489.
61. Peters W., Robinson B.L. The chemotherapy of rodent malaria. Ann. Trop. Med. Parasitol. 93:1999;325-339.
62. Posner G.H., Cumming J.N., Krasavin M. Carbon-centered radicals and rational design of new antimalarials. Torrence P.F., Biomedical Chemistry. Applying Chemical Principles to the Understanding and Treatment of Disease. 2000;289-309 Wiley-Interscience, New York, NY.
63. Posner G.H., Oh C.H., Wang D., Gerena L., Milhous W.K., Meshnick S.R., Asawamahasadka W. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity. J. Med. Chem. 37:1994;1256-1258.
64. Posner G.H., Wang D., Cumming J.N., Oh C.H., French A.N., Bodley A.L., Shapiro T.A. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1,2,4-trioxanes like artemisinin. J. Med. Chem. 38:1995;2273-2275.
65. Price R., van Vugt M., Phaipun L., Luxemburger C., Simpson J., McGready R., ter Kuile F., Kham A., Chongsuphajaisiddhi T., White N.J., Nosten F. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am. J. Trop. Med. Hyg. 60:1999;547-555.
66. Price R.N., Cassar C., Brockman A., Duraisingh M., van Vugt M., White N.J., Nosten F., Krishna S. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 43:1999;2943-2949.
67. Price R.N., Nosten F., Luxemburger C., ter Kuile F.O., Paiphun L., Chongsuphajaisiddhi T., White N.J. Effects of artemisinin derivatives on malaria transmissibility. Lancet. 347:1996;1654-1658.
68. Provot O., Camuzat-Dedenis B., Hamzaoui M., Moskowitz H., Mayrargue J., Robert A., Cazelles J., Meunier B., Zonhiri F., Desmaele D., d'Angelo J., Mahuteau J., Gay F., Ciceron L. Structure-activity relationships of synthetic tricyclic trioxanes related to artemisinin: the unexpected alkylative property of a 3-(methoxymethy) analog. Eur. J. Org. Chem. 8:1999;1935-1938.
69. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 403:2000;906-909.
70. Robert A., Meunier B. Characterization of the first covalent adduct between artemisinin and a heme model. J. Am. Chem. Soc. 119:1997;5968-5969.
71. Rosenthal P.J., Meshnick S.R. Hemoglobin catabolism and iron utilization by malaria parasites. Mol. Biochem. Parasitol. 83:1996;131-139.
72. Sahr F., Willoughby V.R., Gbakima A.A., Bockarie M.J. Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports. Ann. Trop. Med. Parasitol. 95:2001;445-449.
73. Schmuck G., Roehrdanz E., Haynes R.K., Kahl R. Neurotoxic mode of action of artemisinin. Antimicrob. Agents Chemother. 46:2002;821-827.
74. Scott M.D., Meshnick S.R., Williams R.A., Chiu D.T., Pan H.C., Lubin B.H., Kuypers F.A. Qinghaosu-mediated oxidation in normal and abnormal erythrocytes. J. Lab. Clin. Med. 114:1989;401-406.
75. Senok A.C., Nelson E.A., Li K., Oppenheimer S.J. Thalassaemia trait, red blood cell age and oxidant stress: effects on Plasmodium falciparum growth and sensitivity to artemisinin. Trans. R. Soc. Trop. Med. Hyg. 91:1997;585-589.
76. Shukla K.L., Gund T.M., Meshnick S.R. Molecular modeling studies of the artemisinin (qinghaosu)-hemin interaction: docking between the antimalarial agent and its putative receptor. J. Mol. Graph. 13:1995;215-222.
77. Skinner T.S., Manning L.S., Johnston W.A., Davis T.M. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int. J. Parasitol. 26:1996;519-525.
78. Targett G., Drakeley C., Jawara M., von Seidlein L., Coleman R., Deen J., Pinder M., Doherty T., Sutherland C., Walraven G., Milligan P. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J. Infect. Dis. 183:2001;1254-1259.
79. ter Kuile F., White N.J., Holloway P., Pasvol G., Krishna S. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp. Parasitol. 76:1993;85-95.
80. Utzinger J., Shuhua X., N'Goran E.K., Bergquist R., Tanner M. The potential of artemether for the control of schistosomiasis. Int. J. Parasitol. 31:2001;1549-1562.
81. van Vugt M., Brockman A., Gemperli B., Luxemburger C., Gathmann I., Royce C., Slight T., Looareesuwan S., White N.J., Nosten F. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob. Agents Chemother. 42:1998;135-139.
82. van Vugt M., Looareesuwan S., Wilairatana P., McGready R., Villegas L., Gathmann I., Mull R., Brockman A., White N.J., Nosten F. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94:2000;545-548.
83. von Seidlein L., Bojang K., Jones P., Jaffar S., Pinder M., Obaro S., Doherty T., Haywood M., Snounou G., Gemperli B., Gathmann I., Royce C., McAdam K., Greenwood B. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am. J. Trop. Med. Hyg. 58:1998;638-644.
84. Walker D.J., Pitsch J.L., Peng M.M., Robinson B.L., Peters W., Bhisutthibhan J., Meshnick S.R. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii. Antimicrob. Agents Chemother. 44:2000;344-347.
85. Wei N., Sadrzadeh S.M. Enhancement of hemin-induced membrane damage by artemisinin. Biochem. Pharmacol. 48:1994;737-741.
86. White N. Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354:1999;739-749.
87. White N.J. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1997;1413-1422.
88. Wittner M., Lederman J., Tanowitz H.B., Rosenbaum G.S., Weiss L.M. Atovaquone in the treatment of Babesia microti infections in hamsters. Am. J. Trop. Med. Hyg. 55:1996;219-222.
89. Wongsrichanalai C., Nguyen T.D., Trieu N.T., Wimonwattrawatee T., Sookto P., Heppner D.G., Kawamoto F. In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials. Acta Trop. 63:1997;151-158.
90. Wongsrichanalai C., Wimonwattrawatee T., Sookto P., Laoboonchai A., Heppner D.G., Kyle D.E., Wernsdorfer W.H. In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand. Bull. World Health Organ. 77:1999;392-398.
91. Woolfrey J., Avery M., Doweyko A. Comparison of 3D quantitative structure-activity relationship methods: analysis of the in vitro antimalarial activity of 154 artemisinin analogues by hypothetical active-site lattice and comparative molecular field analysis. J. Comput. Aided Mol. Des. 12:1998;165-181.
92. Wu W.-M., Yao J.-J., Jiang K., Wang Y.-F. Ferrous ion induced cleavage of the peroxy bond in quinghaosu and its derivatives and the DNA damage associated with this process. Chem. Commun. 18:1996;2213-2214.
93. Yang Y.Z., Asawamahasakda W., Meshnick S.R. Alkylation of human albumin by the antimalarial artemisinin. Biochem. Pharmacol. 46:1993;336-339.
94. Yang Y.Z., Little B., Meshnick S.R. Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure. Biochem. Pharmacol. 48:1994;569-573.
95. Zhang F., Gosser D.K. Jr, Meshnick S.R. Hemin-catalyzed decomposition of artemisinin (qinghaosu). Biochem. Pharmacol. 43:1992;1805-1809.